Aria CV
PrivateLast Round
Series C
Aug 18, 2025
Est. Valuation
$68.6M
Total Funding Raised
$57.32M
Company Overview
Aria CV is a medical device company that develops implantable systems for the treatment of pulmonary hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aria CV Comparables
Compare Aria CV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulnovo Medical | 78% | |
| Axon Therapies | 71% | |
| CorWave | 70% |
Aria CV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 18, 2025 | ||||
| Debt | Jul 1, 2022 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Series B | Feb 25, 2020 | ||||
| Series A Extension | Mar 12, 2018 | ||||
Series A | Jul 1, 2015 |
Aria CV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cedar Point Capital, LLC | Series A |
| Xeraya Capital | Series B |
| CHV | Series B, Series A |
| KOFA Healthcare | Series C |
| Cedar Point Capital | Series B, Series A |
| BioStar Capital | Series C, Series B |
| Longview Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2025
Raised $4M from KOFA Healthcare and BioStar Capital.
- Feb 25, 2020
$31M round led by Xeraya Capital.
Aria CV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access